List of Tables
Table 1. Global Anti-Obesity Therapeutics Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Anti-Obesity Therapeutics Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Anti-Obesity Therapeutics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-Obesity Therapeutics Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-Obesity Therapeutics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-Obesity Therapeutics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-Obesity Therapeutics Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-Obesity Therapeutics, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Anti-Obesity Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Obesity Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Obesity Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Obesity Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Therapeutics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Obesity Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-Obesity Therapeutics Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-Obesity Therapeutics Sales Market Share by Region (2018-2023)
Table 19. Global Anti-Obesity Therapeutics Sales by Region (2024-2029) & (K Units)
Table 20. Global Anti-Obesity Therapeutics Sales Market Share by Region (2024-2029)
Table 21. Global Anti-Obesity Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-Obesity Therapeutics Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-Obesity Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-Obesity Therapeutics Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-Obesity Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-Obesity Therapeutics Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-Obesity Therapeutics Sales by Country (2024-2029) & (K Units)
Table 28. North America Anti-Obesity Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-Obesity Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-Obesity Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-Obesity Therapeutics Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-Obesity Therapeutics Sales by Country (2024-2029) & (K Units)
Table 33. Europe Anti-Obesity Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-Obesity Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-Obesity Therapeutics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-Obesity Therapeutics Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-Obesity Therapeutics Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Anti-Obesity Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-Obesity Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-Obesity Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-Obesity Therapeutics Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-Obesity Therapeutics Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Anti-Obesity Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-Obesity Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-Obesity Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-Obesity Therapeutics Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-Obesity Therapeutics Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Anti-Obesity Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Obesity Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-Obesity Therapeutics Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-Obesity Therapeutics Sales (K Units) by Type (2024-2029)
Table 52. Global Anti-Obesity Therapeutics Sales Market Share by Type (2018-2023)
Table 53. Global Anti-Obesity Therapeutics Sales Market Share by Type (2024-2029)
Table 54. Global Anti-Obesity Therapeutics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-Obesity Therapeutics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-Obesity Therapeutics Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-Obesity Therapeutics Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-Obesity Therapeutics Price (USD/Unit) by Type (2018-2023)
Table 59. Global Anti-Obesity Therapeutics Price (USD/Unit) by Type (2024-2029)
Table 60. Global Anti-Obesity Therapeutics Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-Obesity Therapeutics Sales (K Units) by Application (2024-2029)
Table 62. Global Anti-Obesity Therapeutics Sales Market Share by Application (2018-2023)
Table 63. Global Anti-Obesity Therapeutics Sales Market Share by Application (2024-2029)
Table 64. Global Anti-Obesity Therapeutics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-Obesity Therapeutics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti-Obesity Therapeutics Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-Obesity Therapeutics Revenue Market Share by Application (2024-2029)
Table 68. Global Anti-Obesity Therapeutics Price (USD/Unit) by Application (2018-2023)
Table 69. Global Anti-Obesity Therapeutics Price (USD/Unit) by Application (2024-2029)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Bristol-Myers Squibb Anti-Obesity Therapeutics Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Eisai Company Corporation Information
Table 76. Eisai Company Description and Business Overview
Table 77. Eisai Company Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Eisai Company Anti-Obesity Therapeutics Product
Table 79. Eisai Company Recent Developments/Updates
Table 80. FlaxoSithKline plc. Corporation Information
Table 81. FlaxoSithKline plc. Description and Business Overview
Table 82. FlaxoSithKline plc. Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. FlaxoSithKline plc. Anti-Obesity Therapeutics Product
Table 84. FlaxoSithKline plc. Recent Developments/Updates
Table 85. Novo Nordisk Corporation Information
Table 86. Novo Nordisk Description and Business Overview
Table 87. Novo Nordisk Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Novo Nordisk Anti-Obesity Therapeutics Product
Table 89. Novo Nordisk Recent Developments/Updates
Table 90. Alizyme Corporation Information
Table 91. Alizyme Description and Business Overview
Table 92. Alizyme Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Alizyme Anti-Obesity Therapeutics Product
Table 94. Alizyme Recent Developments/Updates
Table 95. BoehringerIngelheim GmbH Corporation Information
Table 96. BoehringerIngelheim GmbH Description and Business Overview
Table 97. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product
Table 99. BoehringerIngelheim GmbH Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Pfizer Anti-Obesity Therapeutics Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Takeda Pharmaceutical Corporation Information
Table 106. Takeda Pharmaceutical Description and Business Overview
Table 107. Takeda Pharmaceutical Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Takeda Pharmaceutical Anti-Obesity Therapeutics Product
Table 109. Takeda Pharmaceutical Recent Developments/Updates
Table 110. Rhythm Pharmaceuticals Corporation Information
Table 111. Rhythm Pharmaceuticals Description and Business Overview
Table 112. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product
Table 114. Rhythm Pharmaceuticals Recent Developments/Updates
Table 115. Shionogi USA Corporation Information
Table 116. Shionogi USA Description and Business Overview
Table 117. Shionogi USA Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Shionogi USA Anti-Obesity Therapeutics Product
Table 119. Shionogi USA Recent Developments/Updates
Table 120. Vivus Corporation Information
Table 121. Vivus Description and Business Overview
Table 122. Vivus Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Vivus Anti-Obesity Therapeutics Product
Table 124. Vivus Recent Developments/Updates
Table 125. Zafgen Corporation Information
Table 126. Zafgen Description and Business Overview
Table 127. Zafgen Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Zafgen Anti-Obesity Therapeutics Product
Table 129. Zafgen Recent Developments/Updates
Table 130. Norgine Pharmaceuticals Ltd. Corporation Information
Table 131. Norgine Pharmaceuticals Ltd. Description and Business Overview
Table 132. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product
Table 134. Norgine Pharmaceuticals Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Anti-Obesity Therapeutics Distributors List
Table 138. Anti-Obesity Therapeutics Customers List
Table 139. Anti-Obesity Therapeutics Market Trends
Table 140. Anti-Obesity Therapeutics Market Drivers
Table 141. Anti-Obesity Therapeutics Market Challenges
Table 142. Anti-Obesity Therapeutics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Obesity Therapeutics
Figure 2. Global Anti-Obesity Therapeutics Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Anti-Obesity Therapeutics Market Share by Type in 2022 & 2029
Figure 4. Centrally Acting Anti-obesity Drugs Product Picture
Figure 5. Peripherally Acting Anti-obesity Drugs Product Picture
Figure 6. Global Anti-Obesity Therapeutics Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Anti-Obesity Therapeutics Market Share by Application in 2022 & 2029
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Household
Figure 11. Other
Figure 12. Global Anti-Obesity Therapeutics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Anti-Obesity Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 14. Global Anti-Obesity Therapeutics Sales (2018-2029) & (K Units)
Figure 15. Global Anti-Obesity Therapeutics Average Price (USD/Unit) & (2018-2029)
Figure 16. Anti-Obesity Therapeutics Report Years Considered
Figure 17. Anti-Obesity Therapeutics Sales Share by Manufacturers in 2022
Figure 18. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Anti-Obesity Therapeutics Players: Market Share by Revenue in 2022
Figure 20. Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Anti-Obesity Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Anti-Obesity Therapeutics Sales Market Share by Country (2018-2029)
Figure 23. North America Anti-Obesity Therapeutics Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Anti-Obesity Therapeutics Sales Market Share by Country (2018-2029)
Figure 27. Europe Anti-Obesity Therapeutics Revenue Market Share by Country (2018-2029)
Figure 28. Germany Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Anti-Obesity Therapeutics Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Anti-Obesity Therapeutics Revenue Market Share by Region (2018-2029)
Figure 35. China Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Anti-Obesity Therapeutics Sales Market Share by Country (2018-2029)
Figure 46. Latin America Anti-Obesity Therapeutics Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anti-Obesity Therapeutics Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Anti-Obesity Therapeutics Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Anti-Obesity Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-Obesity Therapeutics by Type (2018-2029)
Figure 56. Global Revenue Market Share of Anti-Obesity Therapeutics by Type (2018-2029)
Figure 57. Global Anti-Obesity Therapeutics Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Anti-Obesity Therapeutics by Application (2018-2029)
Figure 59. Global Revenue Market Share of Anti-Obesity Therapeutics by Application (2018-2029)
Figure 60. Global Anti-Obesity Therapeutics Price (USD/Unit) by Application (2018-2029)
Figure 61. Anti-Obesity Therapeutics Value Chain
Figure 62. Anti-Obesity Therapeutics Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed